This site is best viewed in a modern web browser.
The page you were looking for has either been removed or does not exists.
Necessity of Sustained Funding to Ensure Continued Access to Anti-Vascular Endothelial Growth Factor Drugs to Preserve Vision for Canadians living with Retinal Diseases
Vision loss from nAMD causes significant morbidity in patients, especially in those who have restricted access to prompt care. Maintaining vision in the elderly is critical to improved quality of life and decreased morbidity and mortality from falls.
Think others would like to see this?
{{ commentDocument.title }}
(no article selected)
What are your thoughts {{ profile.displayName }}?
Sign in to comment
What others had to say:
{{ item.user_name }}
No comments yet, you are the first!